419 related articles for article (PubMed ID: 25834315)
1. Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease.
Li LS; Liu CZ; Xu JD; Zheng LF; Feng XY; Zhang Y; Zhu JX
World J Gastroenterol; 2015 Mar; 21(12):3509-18. PubMed ID: 25834315
[TBL] [Abstract][Full Text] [Related]
2. Entacapone promotes cAMP-dependent colonic Cl(-) secretion in rats.
Li LS; Zheng LF; Xu JD; Ji T; Guo H; Li XF; Li Y; Zhang Y; Zhu JX
Neurogastroenterol Motil; 2011 Jul; 23(7):657-e277. PubMed ID: 21501335
[TBL] [Abstract][Full Text] [Related]
3. Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Hamaue N; Ogata A; Terado M; Tsuchida S; Yabe I; Sasaki H; Hirafuji M; Togashi H; Aoki T
Brain Res; 2010 Jan; 1309():110-5. PubMed ID: 19879254
[TBL] [Abstract][Full Text] [Related]
4. Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease.
Najib J
Clin Ther; 2001 Jun; 23(6):802-32; discussion 771. PubMed ID: 11440283
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese formula, lubricating gut pill, improves loperamide-induced rat constipation involved in enhance of Cl- secretion across distal colonic epithelium.
Wu D; Wang X; Zhou J; Yuan J; Cui B; An R; Hu Z
J Ethnopharmacol; 2010 Jul; 130(2):347-53. PubMed ID: 20488235
[TBL] [Abstract][Full Text] [Related]
6. Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations.
Rocha JF; Falcão A; Santos A; Pinto R; Lopes N; Nunes T; Wright LC; Vaz-da-Silva M; Soares-da-Silva P
Eur J Clin Pharmacol; 2014 Sep; 70(9):1059-71. PubMed ID: 24925090
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese formula, lubricating gut pill, stimulates cAMP-dependent CI(−) secretion across rat distal colonic mucosa.
Wu D; Zhou J; Wang X; Cui B; An R; Shi H; Yuan J; Hu Z
J Ethnopharmacol; 2011 Mar; 134(2):406-13. PubMed ID: 21195154
[TBL] [Abstract][Full Text] [Related]
8. Tissue and interspecies comparison of catechol-
Jalkanen A; Lassheikki V; Torsti T; Gharib E; Lehtonen M; Juvonen RO
Xenobiotica; 2021 Mar; 51(3):268-278. PubMed ID: 33289420
[TBL] [Abstract][Full Text] [Related]
9. Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.
Marin C; Aguilar E; Bonastre M; Tolosa E; Obeso JA
Exp Neurol; 2005 Mar; 192(1):184-93. PubMed ID: 15698633
[TBL] [Abstract][Full Text] [Related]
10. Erythrocytes catechol-o-methyl transferase activity is up-regulated after a 3-month treatment by entacapone in parkinsonian patients.
Maltête D; Cottard AM; Mihout B; Costentin J
Clin Neuropharmacol; 2011; 34(1):21-3. PubMed ID: 21164341
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ion transport by 5-hydroxytryptamine in rat colon.
Ning Y; Zhu JX; Chan HC
Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):424-8. PubMed ID: 15236628
[TBL] [Abstract][Full Text] [Related]
12. The effect of catechol-O-methyltransferase inhibition with entacapone on cardiovascular autonomic responses in L-Dopa-treated patients with Parkinson's disease.
Lyytinen J; Sovijärvi A; Kaakkola S; Gordin A; Teräväinen H
Clin Neuropharmacol; 2001; 24(1):50-7. PubMed ID: 11290882
[TBL] [Abstract][Full Text] [Related]
13. Cellular localization of NKCC2 and its possible role in the Cl- absorption in the rat and human distal colonic epithelia.
Zhu JX; Xue H; Ji T; Xing Y
Transl Res; 2011 Sep; 158(3):146-54. PubMed ID: 21867980
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
Lyytinen J; Kaakkola S; Ahtila S; Tuomainen P; Teräväinen H
Mov Disord; 1997 Jul; 12(4):497-505. PubMed ID: 9251066
[TBL] [Abstract][Full Text] [Related]
15. Deoxycholic acid (DOC) affects the transport properties of distal colon.
Mauricio AC; Slawik M; Heitzmann D; von Hahn T; Warth R; Bleich M; Greger R
Pflugers Arch; 2000 Mar; 439(5):532-40. PubMed ID: 10764211
[TBL] [Abstract][Full Text] [Related]
16. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
17. The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats.
Nissinen E; Nissinen H; Larjonmaa H; Väänänen A; Helkamaa T; Reenilä I; Rauhala P
J Neural Transm (Vienna); 2005 Sep; 112(9):1213-21. PubMed ID: 15614425
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
[TBL] [Abstract][Full Text] [Related]
19. Emodin induces chloride secretion in rat distal colon through activation of mast cells and enteric neurons.
Xu JD; Liu S; Wang W; Li LS; Li XF; Li Y; Guo H; Ji T; Feng XY; Hou XL; Zhang Y; Zhu JX
Br J Pharmacol; 2012 Jan; 165(1):197-207. PubMed ID: 21718311
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats.
Marin C; Aguilar E; Obeso JA
Mov Disord; 2006 May; 21(5):646-53. PubMed ID: 16437585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
